General Annual Meeting (GAM)

38th General Annual Meeting of the Belgian Hematology Society - Day 2 - Session II: Highlight 2 – Bispecific monoclonal antibodies

38th General Annual Meeting of the Belgian Hematology Society - Day 2 - Session I: Satellite 2 – Beigene: Next generation BTK inhibitors: what’s in it for our Waldenström patients?

38th General Annual Meeting of the Belgian Hematology Society - Day 1 - Session VIII: Ethics & Economy

38th General Annual Meeting of the Belgian Hematology Society - Day 1 - Session VII: Pierre Stryckmans Lecture

38th General Annual Meeting of the Belgian Hematology Society - Day 1 - Session VI: Special Lecture 2

38th General Annual Meeting of the Belgian Hematology Society - Day 1 - Session V: Oral Abstracts

38th General Annual Meeting of the Belgian Hematology Society - Day 1 - Session IV: Special Lecture 1

38th General Annual Meeting of the Belgian Hematology Society - Day 1 - Session III: Satellite 1 – Amgen: MRD matters: changing the paradigm for hematological malignancies